Hemispherx

is committed to advancing our technology platforms and product candidates. In order to pursue this goal, Hemispherx is highly interested in collaborative opportunities including product out-licensing, co-research, co-development, co-promotion, and co-marketing with research institutes, pharmaceutical companies, and biotech companies domestically and internationally.

Ampligen

  • Cancer
  • Vaccine Adjuvant
  • Broad Spectrum Antiviral
  • Traumatic Injury / Burns Immunodeficiency

Alferon

  • Broad Spectrum Antiviral
  • Genital Warts
  • Anti-Cancer
  • Argentina Approval
  • Intralesional treatment of external genital warts refractory or recurring
  • Treatment patients who initially responded to recombinant interferon alpha, including pegylated interferon alfa, but later treatment failed due to the presence of neutralizing antibodies.

Contact Us

Please direct your inquiries regarding business development and licensing opportunities to: info@hemispherx.net

Hemispherx

is committed to advancing our technology platforms and product candidates. In order to pursue this goal, Hemispherx is highly interested in collaborative opportunities including product out-licensing, co-research, co-development, co-promotion, and co-marketing with research institutes, pharmaceutical companies, and biotech companies domestically and internationally.

Ampligen

  • Cancer
  • Vaccine Adjuvant
  • Broad Spectrum Antiviral
  • Traumatic Injury / Burns Immunodeficiency

Alferon

  • Broad Spectrum Antiviral
  • Genital Warts
  • Anti-Cancer
  • Argentina Approval
  • Intralesional treatment of external genital warts refractory or recurring
  • Treatment patients who initially responded to recombinant interferon alpha, including pegylated interferon alfa, but later treatment failed due to the presence of neutralizing antibodies.

Contact Us

Please direct your inquiries regarding business development and licensing opportunities to: info@hemispherx.net

Questions Or Comments?

If you have any additional questions or comments, click below.

Contact Us